Product Information
TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1561 per EA under NDC 00378204601. Its NADAC has been published 637 times since Nov 28, 2013.
Strength
1 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378204601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA090596On Market Since
9/17/2010
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) has been published 637 times since Nov 28, 2013, and over the history we have for it it has declined 89.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1561 per EA |
|---|---|
| All-time high | $1.6306 (Feb 12, 2014) |
| All-time low | $0.1561 (Jun 17, 2026) |
| 52-week high | $0.1769 |
| 52-week low | $0.1561 |
| Median price | $0.3051 |
| Average price | $0.4655 |
| Largest weekly change | +114.2% (Oct 23, 2019) |
| Weeks tracked | 637 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 13 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE), manufactured by Mylan Pharmaceuticals Inc., is $0.1561 per EA (NDC 00378204601), effective Jun 24, 2026.
How has the price of TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) has declined 89.5%. It has been tracked across 637 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
Since Nov 28, 2013, the NADAC for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) has ranged from a low of $0.1561 (Jun 17, 2026) to a high of $1.6306 (Feb 12, 2014), with a median of $0.3051 per EA.
Are there cheaper alternatives to TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
13 NADAC-published products share the same active ingredient, strength, and dosage form as TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE), but none are currently priced below it.
Who manufactures TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) (NDC 00378204601) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification